中华儿科杂志
中華兒科雜誌
중화인과잡지
Chinese Journal of Pediatrics
2012年
9期
689-691
,共3页
荣星%吴慧平%仇慧仙%任跃%张园海%陈其%吴蓉洲%胡型锑
榮星%吳慧平%仇慧仙%任躍%張園海%陳其%吳蓉洲%鬍型銻
영성%오혜평%구혜선%임약%장완해%진기%오용주%호형제
心脏缺损,先天性%高血压,肺性%尾加压素
心髒缺損,先天性%高血壓,肺性%尾加壓素
심장결손,선천성%고혈압,폐성%미가압소
Congenital heart diseases%Pulmonary hypertension%Urotensins
目的 观察尾加压素Ⅱ在先天性心脏病肺动脉高压患儿肺组织中的表达情况,并探讨其意义.方法 收集温州医学院育英儿童医院28例先天性心脏病伴有肺动脉高压患儿及10例先天性心脏病无肺动脉高压患儿的肺组织,根据肺动脉收缩压(PASP)分为轻度肺高压组(PASP≥30mm Hg,n=15)(1 mm Hg =0.133 kPa)、中重度肺高压组(PASP≥50 mm Hg,n=13)和无肺高压组( PASP< 30 mm Hg,n=10),采用免疫组化及原位杂交的方法检测肺组织中的尾加压素Ⅱ蛋白及mRNA表达变化.本研究获得温州医学院附属第二医院伦理委员会审查通过,入组患儿家长或监护人均签署知情同意书.结果 (1)免疫组化显示:尾加压素Ⅱ蛋白在各组先天性心脏病患儿肺组织中均有表达.轻度肺高压组(20.22 ±3.58)、中重度肺高压组(28.92±3.22)尾加压素Ⅱ蛋白表达高于无肺高压组(14.34 ±2.18)(P均<0.01),中重度肺高压组尾加压素Ⅱ蛋白表达高于轻度肺高压组(P<0.05).(2)原位杂交显示:尾加压素ⅡmRNA在中重度肺高压组表达(25.35 ±4.33)明显高于轻度肺高压组(12.51 ±2.02)及无肺高压组(8.85±1.41)(P均<0.01),轻度肺高压组尾加压素ⅡmRNA表达亦高于无肺高压组(P<0.05).(3)相关分析显示:尾加压素Ⅱ蛋白及mRNA表达与肺动脉压力成正相关关系(r分别为0.64和0.58,P<0.01).结论 先天性心脏病肺动脉高压患儿肺组织中存在尾加压素Ⅱ的表达,可能参与了先天性心脏病肺动脉高压的形成.
目的 觀察尾加壓素Ⅱ在先天性心髒病肺動脈高壓患兒肺組織中的錶達情況,併探討其意義.方法 收集溫州醫學院育英兒童醫院28例先天性心髒病伴有肺動脈高壓患兒及10例先天性心髒病無肺動脈高壓患兒的肺組織,根據肺動脈收縮壓(PASP)分為輕度肺高壓組(PASP≥30mm Hg,n=15)(1 mm Hg =0.133 kPa)、中重度肺高壓組(PASP≥50 mm Hg,n=13)和無肺高壓組( PASP< 30 mm Hg,n=10),採用免疫組化及原位雜交的方法檢測肺組織中的尾加壓素Ⅱ蛋白及mRNA錶達變化.本研究穫得溫州醫學院附屬第二醫院倫理委員會審查通過,入組患兒傢長或鑑護人均籤署知情同意書.結果 (1)免疫組化顯示:尾加壓素Ⅱ蛋白在各組先天性心髒病患兒肺組織中均有錶達.輕度肺高壓組(20.22 ±3.58)、中重度肺高壓組(28.92±3.22)尾加壓素Ⅱ蛋白錶達高于無肺高壓組(14.34 ±2.18)(P均<0.01),中重度肺高壓組尾加壓素Ⅱ蛋白錶達高于輕度肺高壓組(P<0.05).(2)原位雜交顯示:尾加壓素ⅡmRNA在中重度肺高壓組錶達(25.35 ±4.33)明顯高于輕度肺高壓組(12.51 ±2.02)及無肺高壓組(8.85±1.41)(P均<0.01),輕度肺高壓組尾加壓素ⅡmRNA錶達亦高于無肺高壓組(P<0.05).(3)相關分析顯示:尾加壓素Ⅱ蛋白及mRNA錶達與肺動脈壓力成正相關關繫(r分彆為0.64和0.58,P<0.01).結論 先天性心髒病肺動脈高壓患兒肺組織中存在尾加壓素Ⅱ的錶達,可能參與瞭先天性心髒病肺動脈高壓的形成.
목적 관찰미가압소Ⅱ재선천성심장병폐동맥고압환인폐조직중적표체정황,병탐토기의의.방법 수집온주의학원육영인동의원28례선천성심장병반유폐동맥고압환인급10례선천성심장병무폐동맥고압환인적폐조직,근거폐동맥수축압(PASP)분위경도폐고압조(PASP≥30mm Hg,n=15)(1 mm Hg =0.133 kPa)、중중도폐고압조(PASP≥50 mm Hg,n=13)화무폐고압조( PASP< 30 mm Hg,n=10),채용면역조화급원위잡교적방법검측폐조직중적미가압소Ⅱ단백급mRNA표체변화.본연구획득온주의학원부속제이의원윤리위원회심사통과,입조환인가장혹감호인균첨서지정동의서.결과 (1)면역조화현시:미가압소Ⅱ단백재각조선천성심장병환인폐조직중균유표체.경도폐고압조(20.22 ±3.58)、중중도폐고압조(28.92±3.22)미가압소Ⅱ단백표체고우무폐고압조(14.34 ±2.18)(P균<0.01),중중도폐고압조미가압소Ⅱ단백표체고우경도폐고압조(P<0.05).(2)원위잡교현시:미가압소ⅡmRNA재중중도폐고압조표체(25.35 ±4.33)명현고우경도폐고압조(12.51 ±2.02)급무폐고압조(8.85±1.41)(P균<0.01),경도폐고압조미가압소ⅡmRNA표체역고우무폐고압조(P<0.05).(3)상관분석현시:미가압소Ⅱ단백급mRNA표체여폐동맥압력성정상관관계(r분별위0.64화0.58,P<0.01).결론 선천성심장병폐동맥고압환인폐조직중존재미가압소Ⅱ적표체,가능삼여료선천성심장병폐동맥고압적형성.
Objective To observe the expression of urotensin Ⅱ ( U Ⅱ ) on the lung of patients with pulmonary hypertension(PH) with congenital heart disease and investigate the meaning of this phenomenon.Method Thirty eight patients with CHD were divided into three groups according to pulmonary arterial systolic pressure (PASP) measured in cardiac catheterization and surgery:normal pulmonary pressure group (N group,PASP <30 mm Hg,n =10),mild PH group (M group,PASP≥30 mm Hg,n =15),severe or moderate PH group (S group,PASP≥50 mm Hg,n =13).The expression of U Ⅱ protein and U Ⅱ mRNA in pulmonary arterioles were measured separately by immunohistochemical (IHC) analysis and in situ hybridization (ISH) analysis.Result ( 1 ) The results of U Ⅱ IHC staining:The U Ⅱ protein expression of group M was higher than that of group N (20.22 ±3.58 vs.14.34 ±2.18,P <0.01 ),but less than group S (20.22 ± 3.58 vs.28.92 ± 3.22,P < 0.05 ).(2) The results of U Ⅱ ISH mRNA staining were similar to IHC staining,the A value of group M was higher than group N ( 12.51 ±2.02 vs.8.85 ± 1.41,P <0.05),less than that of group S( 12.51 ±2.02 vs.25.35 ±4.33,P <0.01 ).(3) CorTelation study:there was a positive correlation between the A values of U Ⅱ IHC and pulmonary hypertension ( r =0.64,P <0.01,n =38),a positive correlation between the A values of U Ⅱ ISH and pulmonary hypertension ( r =0.58,P <0.01,n =38). Conclusion There was the expression of Urotensin Ⅱ protein and mRNA in the lung of pulmonary hypertension patients with congenital heart disease, and these expression may involve the formation of pulmonary hypertension of congenital heart disease.